Thursday, July 04, 2024 5:13:05 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent REPL News
- Replimune to Present at Two Upcoming Investor Conferences • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 01:28:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/03/2026 01:12:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2026 01:05:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:00:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 10:11:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 10:10:07 PM
- Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/18/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2025 09:30:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/02/2025 09:11:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:31:07 PM
- Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025) • GlobeNewswire Inc. • 11/07/2025 09:45:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/06/2025 09:20:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2025 01:20:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 01:07:55 PM
- Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/06/2025 01:00:00 PM
- Replimune Shares Skyrocket After FDA Accepts Resubmitted BLA for Melanoma Therapy • IH Market News • 10/20/2025 12:11:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2025 11:20:45 AM
- Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma • GlobeNewswire Inc. • 10/20/2025 11:00:00 AM
- Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025 • GlobeNewswire Inc. • 10/19/2025 12:00:00 PM
- Replimune Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights - REPL • PR Newswire (US) • 09/22/2025 12:45:00 PM
- Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REPL • PR Newswire (US) • 09/22/2025 09:35:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 01:20:45 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM

